بدائل البحث:
greater decrease » greater increase (توسيع البحث), greater increases (توسيع البحث), rate decreased (توسيع البحث)
bone disease » borne disease (توسيع البحث), borne diseases (توسيع البحث), bowel disease (توسيع البحث)
a decrease » _ decreased (توسيع البحث), _ decreases (توسيع البحث)
greater decrease » greater increase (توسيع البحث), greater increases (توسيع البحث), rate decreased (توسيع البحث)
bone disease » borne disease (توسيع البحث), borne diseases (توسيع البحث), bowel disease (توسيع البحث)
a decrease » _ decreased (توسيع البحث), _ decreases (توسيع البحث)
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
Candidates from the RF method. The top 25 random forest candidates ranked by mean decrease in accuracy and mean decrease in Gini Index are in the first and second columns, respectively....
منشور في 2025"…The top 25 random forest candidates ranked by mean decrease in accuracy and mean decrease in Gini Index are in the first and second columns, respectively. …"
-
9
-
10
-
11
-
12
-
13
HFD induces LDs and decreases ER and mitochondria in nephrocytes.
منشور في 2021"…(<b>E</b>) Low and high magnification views of pericardial nephrocytes (dotted outlines) from STD and HFD larvae, showing that HFD decreases mitochondria (marked with anti-ATP5A) and ER (marked with anti-KDEL) but increases LDs (marked with LipidTOX). …"
-
14
Bone disease.
منشور في 2024"…</p><p>Method</p><p>We conducted a systematic literature search of PubMed, Embase, Scopus, Cochrane reviews and international conference abstracts for articles that examined for the following non-communicable diseases (NCDs); cardiovascular disease, cancer, frailty, metabolic, bone, renal and neurocognitive disease, in PWH aged >18 years. …"
-
15
-
16
-
17
-
18
-
19
-
20
Table_1_Previous Use of Anti-Vascular Endothelial Growth Factor Receptor Agents Decreases Efficacy of Fruquintinib in Metastatic Colorectal Cancer Refractory to Standard Therapies....
منشور في 2020"…</p>Conclusion<p>Fruquintinib was an effective third-line therapy in mCRC with tolerable AEs. Efficacy of fruquintinib was decreased in patients with previous use of anti-VEGFR agents. …"